[HTML][HTML] Polypeptides-Based Nanocarriers in Tumor Therapy
J You, Y Guo, Z Dong - Pharmaceutics, 2024 - mdpi.com
Cancer remains a worldwide problem, and new treatment strategies are being actively
developed. Peptides have the characteristics of good biocompatibility, strong targeting …
developed. Peptides have the characteristics of good biocompatibility, strong targeting …
[HTML][HTML] Chemotherapeutic potential of Chlorambucil-Platinum (IV) Prodrugs against Cisplatin-resistant colorectal Cancer cells
Chlorambucil-platinum (IV) prodrugs exhibit multi-mechanistic chemotherapeutic activity
with promising anticancer potential. The platinum (II) precursors of the prodrugs have been …
with promising anticancer potential. The platinum (II) precursors of the prodrugs have been …
Anticancer Effect of PtIIPHENSS, PtII5MESS, PtII56MESS and their Platinum (IV)-dihydroxy derivatives Against Triple-Negative Breast Cancer and Cisplatin-Resistant …
Simple Summary Conventional intravenous platinum (II) chemotherapy medications,
including carboplatin, oxaliplatin and cisplatin, have demonstrated remarkable efficacy in …
including carboplatin, oxaliplatin and cisplatin, have demonstrated remarkable efficacy in …
An Overview of Receptor-targeted Nanotechnological Approaches for the Treatment of Metastatic Breast Cancer
Breast cancer (BC) is the second most prevalent cancer among women and can originate
from the tubes, connective tissue, and lobules of the breast. The primary focus of this review …
from the tubes, connective tissue, and lobules of the breast. The primary focus of this review …